摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-{[(2S)-6-fluoro-2-methyl-3,4-dihydro-2H-quinolin-1-yl]carbonyl}benzene-1,3-diol

中文名称
——
中文别名
——
英文名称
4-{[(2S)-6-fluoro-2-methyl-3,4-dihydro-2H-quinolin-1-yl]carbonyl}benzene-1,3-diol
英文别名
(2,4-dihydroxyphenyl)-[(2S)-6-fluoro-2-methyl-3,4-dihydro-2H-quinolin-1-yl]methanone
4-{[(2S)-6-fluoro-2-methyl-3,4-dihydro-2H-quinolin-1-yl]carbonyl}benzene-1,3-diol化学式
CAS
——
化学式
C17H16FNO3
mdl
——
分子量
301.317
InChiKey
MJTMTQQRDNWPGK-JTQLQIEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    60.8
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] TETRAHYDROISOQUINOLINE COMPOUNDS AND THEIR USE AS PYRUVATE DEHYDROGENASE KINASE INHIBITORS<br/>[FR] COMPOSÉS TÉTRAHYDROISOQUINOLÉINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA PYRUVATE DÉSHYDROGÉNASE KINASE
    申请人:VERNALIS R & D LTD
    公开号:WO2015040424A1
    公开(公告)日:2015-03-26
    A compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein: R1 is H, Cl, F, CH3 or CF3; R2 is H, C1-C6 alkyl or optionally substituted heteroaryl or optionally substituted aryl; and R3 is (Alk)n-Rn-(Alk)n-Rn-(Alk)n-X. The compounds are useful as tetrahydroisoquinoline (THQ) compounds, which are suitable for use as PDK inhibitors, for example for inhibition of cancer cell proliferation.
    一种具有以下化学式(I)的化合物或其药用可接受的盐,其中:R1为H、Cl、F、CH3或CF3;R2为H、C1-C6烷基或可选择取代的杂环烷基或可选择取代的芳基;R3为(Alk)n-Rn-(Alk)n-Rn-(Alk)n-X。这些化合物可用作四氢异喹啉(THQ)化合物,适用于用作PDK抑制剂,例如用于抑制癌细胞增殖。
  • Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase
    作者:Paul A. Brough、Lisa Baker、Simon Bedford、Kirsten Brown、Seema Chavda、Victoria Chell、Jalanie D’Alessandro、Nicholas G. M. Davies、Ben Davis、Loic Le Strat、Alba T. Macias、Daniel Maddox、Patrick C. Mahon、Andrew J. Massey、Natalia Matassova、Sean McKenna、Johannes W. G. Meissner、Jonathan D. Moore、James B. Murray、Christopher J. Northfield、Charles Parry、Rachel Parsons、Stephen D. Roughley、Terry Shaw、Heather Simmonite、Stephen Stokes、Allan Surgenor、Emma Stefaniak、Alan Robertson、Yikang Wang、Paul Webb、Neil Whitehead、Mike Wood
    DOI:10.1021/acs.jmedchem.6b01478
    日期:2017.3.23
    Libraries of nonpurified resorcinol amide derivatives were screened by surface plasmon resonance (SPR) to determine the binding dissociation constant (off-rate, k(d)) for compounds binding to the pyruvate dehydrogenase kinase (PDHK) enzyme. Parallel off-rate measurements against HSP90 and application of structure-based drug design enabled rapid hit to lead progression in a program to identify pan-isoform ATP-competitive inhibitors of PDHK. Lead optimization identified selective sub-100-nM inhibitors of the enzyme which significantly reduced phosphorylation of the E1 alpha subunit in the PC3 cancer cell line in vitro.
查看更多